FDA: Tougher warnings, dose limits for Tylenol

Drugmakers should limit doses and strengthen warnings on Johnson and Johnson's Tylenol and other medicines containing acetaminophen to reduce the risk of liver injury, according to a U.S. report. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.